Search Results
Results found for "mu-opioid receptor"
- Dr. Bianca Plouffe | Dr. GPCR Ecosystem
same university in 2005 by investigating the molecular mechanisms involved in the angiotensin type 2 receptor She identified the molecular mechanisms involved in the opposite regulation of dopamine D1 and D5 receptors She identified the structural determinant controlling biased signaling of melatonin type 2 receptors Award, she investigated biased and compartmentalized G protein signaling by the vasopressin type 2 receptor understanding the role of compartmentalized Gq signaling by the cytomegalovirus-encoded chemokine US28 receptor
- The Scientist's Compass: From Academia to Entrepreneurship with Dr. Dmitry Veprintsev | Dr. GPCR Ecosystem
Protein Folding to GPCRs – How Dmitry transitioned from biophysics and protein folding to cannabinoid receptor Interdisciplinary Research & Future Directions – Exploring combinatorial drug actions, receptor interactions Nottingham, where he provides leadership in structural and biophysical pharmacology of G protein coupled receptors and ETH Zürich in Switzerland, changing his attention to structural pharmacology of G protein-coupled receptors In 2017 Dmitry became a full professor at the Centre of Membrane Proteins and Receptors, COMPARE, a joined
- Dr. Randy Hall | Dr. GPCR Ecosystem
graduate school at the University of California at Irvine, studying the regulation of ionotropic glutamate receptors , Oregon, to do a post-doctoral fellowship in the laboratory of Thomas Soderling studying glutamate receptor continued his post-doctoral training at Duke University, where he studied the regulation of adrenergic receptors contributions to understanding the signaling, regulation and in vivo actions of the neuroprotective receptors Randy’s lab has a special interest in studying disease-associated mutations to human GPCRs that perturb receptor
- ep 175 with jens carlsson clip 1 | Dr. GPCR Ecosystem
Uppsala University is redefining GPCR drug discovery with predictive molecular modeling that forecasts receptor Their lab doesn’t just simulate receptor-ligand interactions after the fact; they aim to forecast receptor Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism Drug discovery often assumes receptor remains one of the few conceptual anchors that can tell us when “simple” truly is simple—and when deeper receptor Breakthroughs this week: Orphan receptor GPRC5B in neurogenesis; Septerna’s pill-based weight-loss strategy
- Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Structural Determinants Of GAIN Domain Autoproteolysis And Cleavage Resistance Of Adhesion G Protein-Coupled Receptors The GPCR autoproteolysis-inducing (GAIN) domain is a hallmark feature of adhe-sion G-protein coupled receptors We de-termined the crystal structure of the human ADGRB2/BAI2 hormone receptor (HormR) and GAIN domains domains which regulates signaling Sumit Bandekar Abstract "Cadherin EGF Laminin G seven-pass G-type receptors (CELSRs) are conserved adhesion G protein-coupled receptors; they are essential for embryogenesis and
- Dr. GPCR Team | Dr. GPCR Ecosystem
GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and I investigated the effect of lung cancer-related mutations in the GAIN domain of the Latrophilin 3 receptor
- Signals, pH, and Discovery : Cracking GPCR Mysteries with Dr. Ian Chronis | Dr. GPCR Ecosystem
and the University of Michigan shaped his scientific curiosity, particularly around G protein-coupled receptors His research centers on the beta-2 adrenergic receptor and GPR65 , a proton-sensing receptor with promising therapeutic potential of GPR65, especially in the context of cancer immunotherapy, and how understanding receptor My research has looked at the trafficking and signaling of adrenergic and proton-sensing receptors, with
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
Jean-Philippe Pin Jean-Philippe Pin participated in the discovery of metabotropic glutamate receptors been studying the allosteric modulation and activation mechanism of this family of G protein-coupled receptors His studies led to new concepts in the GPCR field, such as the activation of cell surface receptors by
- Dr. Terry Hébert | Dr. GPCR Ecosystem
Today he and his team are working on understanding receptor signaling in specialized cellular environments to gain a better grasp of receptor function in pathophysiological settings with a special interest in His favorite GPCR is the angiotensin 1 receptor, especially for its ability to activate a large variety
- Dr. Robert F. Bruns | Dr. GPCR Ecosystem
doctoral dissertation was the first large-scale study of structure-activity relationships for adenosine receptors postdoc with John W Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the first adenosine receptor He then joined WL/PD, where his lab demonstrated the existence of two subtypes of the adenosine A2 receptor In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
Duke University (1994-1997), where he and his colleagues investigated the role of G protein-coupled receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking, and signaling His research career has focused on the investigation of the regulation of G protein-coupled receptors Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor
- Dr. Chris Tate | Dr. GPCR Ecosystem
basis of GPCR pharmacology through structure determination of the β1-adrenoceptor and adenosine A2A receptor Structures have been determined by X-ray crystallography of receptors coupled to either mini-Gs or mini-Go , and also by electron cryo-microscopy of receptors coupled to mini G protein bound to βγ subunits. a GPCR bound to a biased agonist and coupled to arrestin and also the first structure of a Class D receptor
- Dr. Stephen Ferguson | Dr. GPCR Ecosystem
Duke University (1994-1997), where he and his colleagues investigated the role of G protein-coupled receptor kinases and beta-arrestin in regulating G protein-coupled receptor endocytosis, trafficking, and signaling His research career has focused on the investigation of the regulation of G protein-coupled receptors Institutes of Health Research (CIHR) for his research investigating the role of metabotropic glutamate receptor
- Dr. Sudarshan Rajagopal | Dr. GPCR Ecosystem
the development of approaches to quantify ligand bias and the identification of beta-arrestin-biased receptors The main focus of his lab’s research is on the mechanisms underlying biased agonism at chemokine receptors The chemokine system is relatively unique in having multiple receptors and multiple ligands that display His group and others have shown that many of these ligands act as biased agonists for the same receptor
- Session II | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
signaling pathways and trafficking Localization of putative ligands for adhesion G protein-coupled receptors Yuling Feng The ADGRF5/GPR116 receptor is a key regulator of lymphatic endothelial cell identity and Yuling Feng on the web LinkedIn The ADGRF5/GPR116 receptor is a key regulator of lymphatic endothelial Autoproteolysis-Inducing (GAIN) domain of Latrophilin 3 receptor under the mentorship of Dr. These cleaved fragments join to form the heteromeric ADGRG6 receptor complex.
- How do GRK-specific phosphorylation barcodes influence β-arrestin binding to GPCRs? New cryo-EM structures from Chen et al. (Nature, 2025) reveal that β-arrestin1 and β-arrestin2 form distinct complexes with ACKR3 depending on whether it's phosphorylated by GRK2 or GRK5, shaping arrestin conformation, complex stability, and engagement mode. Surprisingly, arrestin’s finger loop didn’t dive into the receptor core. Instead, it latched onto the micelle surface, breaking canonical expectations. Also, β-arrestin2 lacks a membrane anchor, making it more dynamic — a potential clue to its functional specialization. These findings underscore how barcode location + arrestin isoform = unique signaling outcomes. open book Read the full study: Inside Out: Mapping GPCRs from Membrane Codes to Market Moves #GPCRs #Arrestin #ACKR3 #GRKs #CryoEM #StructuralBiology #SignalingBias #Phosphorylation #DrGPCR | Dr. GPCR Ecosystem
Surprisingly, arrestin’s finger loop didn’t dive into the receptor core. Surprisingly, arrestin’s finger loop didn’t dive into the receptor core.
- A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice
Sponsors GPCR Retreat Program < Back to schedule A positive Allosteric Modulator of M1 Acetylcholine Receptors Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel G protein-coupled receptor
- Smells Like GPCR Spirit: Cracking Olfactory Codes with Alessandro Nicoli | Dr. GPCR Ecosystem
GPCRs, Receptors of Infinite Variety When asked about his favorite GPCR, Nicoli refused to pick. .” – Alessandro Nicoli He emphasized that olfactory receptors , while underexplored, present an incredible Modeling the Invisible: Olfactory Receptors Nicoli’s work centers on predicting ligand binding and receptor – Alessandro Nicoli He shared a detailed case study of working on a specific odorant receptor (R5VK1) His research focuses on a group of 400 transmembrane proteins known as olfactory receptors, which mediate
- GPCR Pharmacology, Career Twists & Serendipity with Sokhom Pin | Dr. GPCR Ecosystem
eventually founding in vitro pharmacology departments, Sokhom always stayed anchored to G protein-coupled receptors Sokhom recalls how binding assays at BMS introduced him to the depth and complexity of receptor pharmacology There’s allosterism, receptor desensitization… it opened a whole new world.” PhD entirely in the industry setting—efficient, targeted, and rooted in real-world projects like CGRP receptor He blends classical receptor pharmacology with biosensor technology, always adapting to new tools and
- Dr. G. Aditya Kumar | Dr. GPCR Ecosystem
at Hyderabad, India, where he studied the interaction of membrane cholesterol with the serotonin-1A receptor and its effects on receptor signaling and endocytosis. molecular pharmacology, subcellular trafficking, and membrane biology to better understand how the dynamic receptor
- Leadership, Impact, and GPCR Signaling with Dr. Michelle Halls | Dr. GPCR Ecosystem
From early discoveries in cyclic AMP signaling to uncovering ultrasensitive receptor responses at femtomolar ligand concentrations, her work highlights why receptor localization and protein complex assembly matter high-throughput GPCR screens. ⸻ Inside This Episode How ultrasensitive GPCR signaling emerges from pre-assembled receptor–effector Why receptor localization and scaffolding dramatically shift functional readouts in disease models. The moment when femtomolar ligand concentrations uncovered unexpected receptor sensitivity.
- Dr. Richard Premont | Dr. GPCR Ecosystem
York) in 1990 and 1992, working with Ravi Iyengar on regulation/desensitization of the liver glucagon receptor His initial project to identify and clone taste receptors was unsuccessful, but led to the identification For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling particularly by the G protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination
- Dr. Richard Premont | Dr. GPCR Ecosystem
York) in 1990 and 1992, working with Ravi Iyengar on regulation/desensitization of the liver glucagon receptor His initial project to identify and clone taste receptors was unsuccessful, but led to the identification For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling particularly by the G protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination
- Dr. Richard Premont | Dr. GPCR Ecosystem
York) in 1990 and 1992, working with Ravi Iyengar on regulation/desensitization of the liver glucagon receptor His initial project to identify and clone taste receptors was unsuccessful, but led to the identification For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling particularly by the G protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination
- Dr. Richard Premont | Dr. GPCR Ecosystem
York) in 1990 and 1992, working with Ravi Iyengar on regulation/desensitization of the liver glucagon receptor His initial project to identify and clone taste receptors was unsuccessful, but led to the identification For this, we have worked in three main areas: the regulation of G protein-coupled receptor signaling particularly by the G protein-coupled receptor kinase (GRK) – beta-arrestin system, the coordination
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor
- Illuminating Functional Selectivity and Allosterism at GPCRs.
his research program focuses on the molecular and cellular mechanisms regulating G protein-coupled receptor (GPCR) responses, a class of receptors involved in many, if not all, physiological responses, with the He has developed innovative methods for in-cellulo measurement of protein-protein interactions, receptor
- Dr. GPCR Community Presentation | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
focused on investigating the cellular effects of missense lung cancer-mutations in the G-protein-coupled receptor Autoproteolysis-Inducing (GAIN) domain of Latrophilin 3 receptor under the mentorship of Dr.

























